These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

105 related items for PubMed ID: 22416829

  • 1. A case of serial nightmares and oneiroid state under paroxetine for senile depression.
    Kobayashi T, Yamauchi M.
    Psychogeriatrics; 2012 Mar; 12(1):54-7. PubMed ID: 22416829
    [Abstract] [Full Text] [Related]

  • 2. Possible neuroleptic malignant syndrome related to concomitant treatment with paroxetine and alprazolam.
    Tanii H, Ichihashi K, Inoue K, Fujita K, Okazaki Y.
    Prog Neuropsychopharmacol Biol Psychiatry; 2006 Aug 30; 30(6):1176-8. PubMed ID: 16720068
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Duloxetine in the acute and long-term treatment of major depressive disorder: a placebo- and paroxetine-controlled trial.
    Detke MJ, Wiltse CG, Mallinckrodt CH, McNamara RK, Demitrack MA, Bitter I.
    Eur Neuropsychopharmacol; 2004 Dec 30; 14(6):457-70. PubMed ID: 15589385
    [Abstract] [Full Text] [Related]

  • 6. Induction of mania in depression by paroxetine.
    Morishita S, Arita S.
    Hum Psychopharmacol; 2003 Oct 30; 18(7):565-8. PubMed ID: 14533140
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. A double-blind study comparing paroxetine and maprotiline in depressed outpatients.
    Szegedi A, Wetzel H, Angersbach D, Dunbar GC, Schwarze H, Philipp M, Benkert O.
    Pharmacopsychiatry; 1997 May 30; 30(3):97-105. PubMed ID: 9211571
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Withdrawal after discontinuation of paroxetine.
    Arya DK.
    Aust N Z J Psychiatry; 1996 Oct 30; 30(5):702. PubMed ID: 8902183
    [No Abstract] [Full Text] [Related]

  • 13. Hair loss associated with paroxetine treatment: a case report.
    Zalsman G, Sever J, Munitz H.
    Clin Neuropharmacol; 1999 Oct 30; 22(4):246-7. PubMed ID: 10442258
    [Abstract] [Full Text] [Related]

  • 14. Exacerbation of extrapyramidal symptoms with paroxetine.
    Arya DK, McKenzie J, Worrall N.
    Aust N Z J Psychiatry; 1995 Sep 30; 29(3):521-2. PubMed ID: 8573063
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. [Paroxetine in the treatment of depression in geriatric patients--a double-blind comparative study with fluoxetine].
    Schöne W, Ludwig M.
    Fortschr Neurol Psychiatr; 1994 Sep 30; 62 Suppl 1():16-8. PubMed ID: 7959520
    [Abstract] [Full Text] [Related]

  • 18. Successful treatment by paroxetine of delusional disorder, somatic type, accompanied by severe secondary depression.
    Hayashi H, Akahane T, Suzuki H, Sasaki T, Kawakatsu S, Otani K.
    Clin Neuropharmacol; 2010 Sep 30; 33(1):48-9. PubMed ID: 19935408
    [Abstract] [Full Text] [Related]

  • 19. [Unipolar depression suddenly switches to hypomania in a patient who has just started taking venlafaxine].
    Krol DG, Nolen WA.
    Tijdschr Psychiatr; 2006 Sep 30; 48(5):405-8. PubMed ID: 16956033
    [Abstract] [Full Text] [Related]

  • 20. Comparisons of the efficacy and tolerability of extended-release venlafaxine, mirtazapine, and paroxetine in treatment-resistant depression: a double-blind, randomized pilot study in a Chinese population.
    Fang Y, Yuan C, Xu Y, Chen J, Wu Z, Cao L, Yi Z, Hong W, Wang Y, Jiang K, Gao K, Cui X, Nierenberg AA, OPERATION Study Team.
    J Clin Psychopharmacol; 2010 Aug 30; 30(4):357-64. PubMed ID: 20571433
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.